Literature DB >> 31334542

Ionizable amino lipid interactions with POPC: implications for lipid nanoparticle function.

M Ramezanpour1, M L Schmidt, I Bodnariuc, J A Kulkarni, S S W Leung, P R Cullis, J L Thewalt, D P Tieleman.   

Abstract

Lipid nanoparticles (LNPs) composed of ionizable cationic lipids are currently the leading systems for siRNA delivery in liver disease, with the major limitation of low siRNA release efficacy into the cytoplasm. Ionizable cationic lipids are known to be of critical importance in LNP structure and stability, siRNA entrapment, and endosomal disruption. However, their distribution inside the LNPs and their exact role in cytoplasmic delivery remain unclear. A recent study [Kulkarni et al., On the formation and morphology of lipid nanoparticles containing ionizable cationic lipids and siRNA, ACS Nano, 2018, 12(5), 4787-4795] on LNP-siRNA systems containing the ionizable lipid DLin-KC2-DMA (also known as KC2 with an apparent pKa of ca. 6.7) suggested that neutral KC2 segregates from other components and forms an amorphous oil droplet in the core of LNPs. In this paper, we present evidence supporting the model proposed by Kulkarni et al. We studied KC2 segregation in the presence of POPC using molecular dynamics simulation, deuterium NMR, SAXS, and cryo-TEM experiments, and found that neutral KC2 has a high tendency to separate from POPC dispersions. KC2 confinement, upon raising the pH during the formulation process, could result in rearrangement of the internal structure of LNPs. As interactions between cationic KC2 and anionic endosomal lipids are thought to be a key factor in cargo release, KC2 confinement inside the LNP may be responsible for the observed low release efficacy.

Entities:  

Year:  2019        PMID: 31334542     DOI: 10.1039/c9nr02297j

Source DB:  PubMed          Journal:  Nanoscale        ISSN: 2040-3364            Impact factor:   7.790


  9 in total

1.  Computational Insights into the Role of Cholesterol in Inverted Hexagonal Phase Stabilization and Endosomal Drug Release.

Authors:  Mohsen Ramezanpour; D Peter Tieleman
Journal:  Langmuir       Date:  2022-06-08       Impact factor: 4.331

Review 2.  The role of lipid components in lipid nanoparticles for vaccines and gene therapy.

Authors:  Camilla Hald Albertsen; Jayesh A Kulkarni; Dominik Witzigmann; Marianne Lind; Karsten Petersson; Jens B Simonsen
Journal:  Adv Drug Deliv Rev       Date:  2022-07-03       Impact factor: 17.873

Review 3.  Delivery technologies for in utero gene therapy.

Authors:  Rohan Palanki; William H Peranteau; Michael J Mitchell
Journal:  Adv Drug Deliv Rev       Date:  2020-11-09       Impact factor: 15.470

4.  Helper lipid structure influences protein adsorption and delivery of lipid nanoparticles to spleen and liver.

Authors:  Rui Zhang; Rakan El-Mayta; Timothy J Murdoch; Claude C Warzecha; Margaret M Billingsley; Sarah J Shepherd; Ningqiang Gong; Lili Wang; James M Wilson; Daeyeon Lee; Michael J Mitchell
Journal:  Biomater Sci       Date:  2021-01-06       Impact factor: 6.843

Review 5.  The Importance of Apparent pKa in the Development of Nanoparticles Encapsulating siRNA and mRNA.

Authors:  Pratikkumar Patel; Nurudeen Mohammed Ibrahim; Kun Cheng
Journal:  Trends Pharmacol Sci       Date:  2021-04-16       Impact factor: 17.638

Review 6.  Rationale and Application of PEGylated Lipid-Based System for Advanced Target Delivery of siRNA.

Authors:  Xuemei Ge; Lijuan Chen; Bo Zhao; Weien Yuan
Journal:  Front Pharmacol       Date:  2021-01-20       Impact factor: 5.810

Review 7.  Lipid-Based Nanoparticles in the Clinic and Clinical Trials: From Cancer Nanomedicine to COVID-19 Vaccines.

Authors:  Thai Thanh Hoang Thi; Estelle J A Suys; Jung Seok Lee; Dai Hai Nguyen; Ki Dong Park; Nghia P Truong
Journal:  Vaccines (Basel)       Date:  2021-04-08

Review 8.  Nanomedicines to Deliver mRNA: State of the Art and Future Perspectives.

Authors:  Itziar Gómez-Aguado; Julen Rodríguez-Castejón; Mónica Vicente-Pascual; Alicia Rodríguez-Gascón; María Ángeles Solinís; Ana Del Pozo-Rodríguez
Journal:  Nanomaterials (Basel)       Date:  2020-02-20       Impact factor: 5.076

Review 9.  Modification of Lipid-Based Nanoparticles: An Efficient Delivery System for Nucleic Acid-Based Immunotherapy.

Authors:  Chi Zhang; Yifan Ma; Jingjing Zhang; Jimmy Chun-Tien Kuo; Zhongkun Zhang; Haotian Xie; Jing Zhu; Tongzheng Liu
Journal:  Molecules       Date:  2022-03-17       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.